These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7466718)

  • 1. Clinical observations with Rigevidon.
    Bálint S
    Ther Hung; 1980; 28(2):75-8. PubMed ID: 7466718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observations with a combined oral contraceptive (Rigevidon) containing minimum oestrogen dose.
    Karsay K
    Ther Hung; 1980; 28(1):17-20. PubMed ID: 7281074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with hormonal contraceptives.
    Kulakov VI
    Acta Med Hung; 1986; 43(2):93-6. PubMed ID: 3588163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinico-pharmacological examinations with Ovidon.
    Farkas M
    Ther Hung; 1980; 28(3):118-28. PubMed ID: 7221971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of a combined oral contraceptive on lactation and growth of the infant].
    Peralta O; Díaz S; Juez G; Herreros C; Casado ME; Salvatierra AM; Miranda P; Croxatto H
    Rev Chil Obstet Ginecol; 1983; 48(5):372-80. PubMed ID: 6681210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between vascular headaches and low-dose oral contraceptives.
    Karsay K
    Ther Hung; 1990; 38(4):181-5. PubMed ID: 2094059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinico-laboratory research on the pharmacodynamic characteristics of Rigevidon].
    Korkhov VV; Nikanorova SA
    Farmakol Toksikol; 1987; 50(1):97-100. PubMed ID: 3556564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of hormonal contraceptives on menstrual and reproductive function of women].
    Dubnitskaia LV; Sotnikova EI
    Akush Ginekol (Mosk); 1990 Apr; (4):57-60. PubMed ID: 1696071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical use of combined contraceptive preparations of Hungarian manufacture].
    Farkas M
    Akush Ginekol (Mosk); 1983 Nov; (11):11-4. PubMed ID: 6364870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical trial of the combined contraceptive preparation, Ovidon].
    Nalbanski B
    Akush Ginekol (Sofiia); 1979; 18(5):388-91. PubMed ID: 391067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
    Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in arterial blood pressure of women using hormonal contraceptives in relation to their cardiovascular history].
    Manuilova IA; Dubnitskaia LV; Korsakov SG
    Akush Ginekol (Mosk); 1989 Jul; (7):48-51. PubMed ID: 2478038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of Rigevidon used for contraception].
    Marianowski L; Grezechocińska B
    Ginekol Pol; 1984 Aug; 55(8):631-5. PubMed ID: 6396173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of Ovidon, Rigevidon and Postinor for contraception].
    Kulakov VI; Barinov AM; Prilepskaia VN
    Akush Ginekol (Mosk); 1983 Nov; (11):22-4. PubMed ID: 6666791
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular biology and oral contraception.
    Briggs MH; Briggs M
    N Z Med J; 1976 Apr; 83(562):257-61. PubMed ID: 183175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in laboratory tests after treatment with a new contraceptive agent].
    Cervantes LF; López Barcena J; Calderón Márquez JJ
    Ginecol Obstet Mex; 1978 Apr; 43(258):285-97. PubMed ID: 80349
    [No Abstract]   [Full Text] [Related]  

  • 17. Observations with Ovidon.
    Farkas M; Falkay G; Szigethy A
    Ther Hung; 1977; 25(3):93-101. PubMed ID: 929481
    [No Abstract]   [Full Text] [Related]  

  • 18. [Oral-cytological studies on the effect of combined contraceptive preparations as compared to menstruation and pregnancy].
    Zellner P; Klinger G
    Stomatol DDR; 1982 Oct; 32(10):673-7. PubMed ID: 6190274
    [No Abstract]   [Full Text] [Related]  

  • 19. Rationale for new oral contraceptive dosing.
    Williams JK
    Int J Fertil Womens Med; 2004; 49(1):30-5. PubMed ID: 15038507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.